Article
[p53 mutation does not determine prognosis in non-Hodgkin's lymphoma].
Gan to kagaku ryoho. Cancer & chemotherapy - 1 Feb 1997
Osada M, Ishioka C, Murakawa Y, Ichinohasama R, Kanamaru R, Ikawa S
Abstract excerpt
We studied the clinical significance of the extent of p53 protein expression by immunohistochemical analysis and p53 mutations by functional analysis of p53 in 42 patients with high and intermediate grade of Non-Hodgkin's Lymphoma (NHL). Neither p53 expression nor mutation correlated with short survival or resistance to chemoradiotherapy, implying that p53 mutation is not a prognostic factor in NHL.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
